Inactive Instrument

News Renalytix Ai PLC London S.E.

Equities

Pentwater Capital Management LP - Form 8.3 - Renalytix PLC	07-01	PR
ADRs Advance; Connect Biopharma Holdings Climbs 19%	06-28	DJ
EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	06-28	AN
Pentwater Capital Management LP - Form 8.3 - Renalytix plc	06-28	PR
Renalytix Requests Nasdaq Hearing to Address Listing Compliance	06-28	MT
Renalytix Requests Hearing With Nasdaq to Maintain Listing	06-28	MT
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	06-27	PR
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	06-26	PR
Shares in Renalytix plunge on possible ADS suspension on Nasdaq	06-25	AN
Renalytix to Appeal Nasdaq Delisting Over Non-compliance	06-25	MT
Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination	06-14	MT
Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test	06-14	MT
Shares in Renalytix jump as Medicare issues LCD for kidneyintelX.dkd	06-14	AN
Certain Ordinary Shares of Renalytix Plc are subject to a Lock-Up Agreement Ending on 11-JUN-2024.	06-10	CI
Renalytix Files Registration Statement on Behalf of Selling Shareholders	06-06	MT
EXECUTIVE CHANGES: Resolute Mining hires former Acacia exec as chair	05-29	AN
Renalytix Plc Designates Joel R. Jung as Principal Accounting Officer	05-28	CI
Renalytix CFO Steps Down; Interim Successor Named	05-28	MT
Renalytix plc Announces Chief Financial Officer Changes	05-28	CI
Renalytix Plans to Sell American Depositary Shares for Up to $15 Million	05-21	MT

No results for this search